Faculty Opinions recommendation of Tiplaxtinin, a novel, orally efficacious inhibitor of plasminogen activator inhibitor-1: design, synthesis, and preclinical characterization.
2004 ◽
Vol 47
(14)
◽
pp. 3491-3494
◽
2008 ◽
Vol 18
(24)
◽
pp. 6419-6422
◽
2002 ◽
Vol 277
(36)
◽
pp. 32677-32682
◽
1996 ◽
Vol 27
(2)
◽
pp. 64
◽
2008 ◽
Vol 12
(11)
◽
pp. 1313-1320
◽
2014 ◽
Vol 24
(10)
◽
pp. 2379-2382
◽